Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-121 manufacturers

Filters

Filters

Filters , active

Country of origin : China
None products found

pp-121

Capsules

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
China
Comments
Indication: Acute graft-versus-host disease (aGVHD), including steroid-refractory cases in post-allogeneic hematopoietic stem cell transplant patients; potential expansion into fibrotic and inflammatory diseases (e.g., IPF, IBD in earlier research settings) Clinical stage: Phase 1 completed; Phase 1b ongoing in aGVHD patients (global development in early clinical stage) Modality: Small molecule Mechanism / Target: Selective RIPK1 (Receptor-interacting serine/threonine-protein kinase 1) inhibitor, blocking necroptosis signaling and downstream inflammatory cytokine release, reducing tissue damage and immune-mediated inflammation Route / form: Oral capsules Differentiation: First-in-class approach targeting regulated cell death (necroptosis) rather than broad immunosuppression; designed for selective control of inflammatory tissue injury in severe immune-mediated conditions with limited treatment options such as aGVHD; potential to expand into multiple high-unmet-need inflammatory diseases
Manufacturer #39107

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.